Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Naureen Quibria is an analyst at Capital One. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/02/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/29/2024 | BMEA | Buy Now | Biomea Fusion | $2.10 | 1090.42% | Naureen Quibria20% | → $25 | Initiates | → Overweight | Get Alert |
| 05/17/2024 | IMMP | Buy Now | Immutep | $1.68 | 495.24% | Naureen Quibria20% | → $10 | Initiates | → Overweight | Get Alert |
| 03/11/2024 | ERAS | Buy Now | Erasca | $1.26 | 534.92% | Naureen Quibria20% | → $8 | Initiates | → Overweight | Get Alert |
| 10/03/2023 | CARM | Buy Now | CARISMA Therapeutics | $0.23 | 4247.83% | Naureen Quibria20% | → $10 | Initiates | → Overweight | Get Alert |
| 08/16/2023 | IMCR | Buy Now | Immunocore Hldgs | $29.43 | 185.42% | Naureen Quibria20% | → $84 | Initiates | → Overweight | Get Alert |
| 04/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Naureen Quibria20% | — | Downgrade | Buy → Hold | Get Alert |
| 02/08/2023 | DAWN | Buy Now | Day One Biopharmaceutical | $7.80 | 412.82% | Naureen Quibria20% | → $40 | Initiates | → Overweight | Get Alert |
| 09/07/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $6.09 | 80.62% | Naureen Quibria20% | → $11 | Initiates | → Overweight | Get Alert |
| 09/07/2022 | CMRX | Buy Now | Chimerix | $8.51 | -17.74% | Naureen Quibria20% | → $7 | Initiates | → Overweight | Get Alert |
| 05/10/2022 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Naureen Quibria20% | → $70 | Initiates | → Buy | Get Alert |
| 01/13/2022 | GNTA | Buy Now | Genenta Science | $3.80 | 452.63% | Naureen Quibria20% | → $21 | Initiates | → Buy | Get Alert |
| 12/20/2021 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | Naureen Quibria20% | → $22 | Initiates | → Buy | Get Alert |
| 10/14/2021 | KZIA | Buy Now | Kazia Therapeutics | $0.71 | 2430.93% | Naureen Quibria20% | → $180 | Initiates | → Buy | Get Alert |
| 04/29/2021 | CMRX | Buy Now | Chimerix | $8.51 | 135.02% | Naureen Quibria20% | → $20 | Initiates | → Buy | Get Alert |
| 03/16/2021 | ONCR | Buy Now | Oncorus | — | — | Naureen Quibria20% | → $35 | Initiates | → Buy | Get Alert |
